Titre:
  • Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated).
Auteur:Shorr, Andrew F; Janes, Jonathan; Artigas, Antonio; Tenhunen, Jyrki; Wyncoll, Duncan L A; Mercier, Emmanuelle; Francois, Bruno; Vincent, Jean Louis; Vangerow, Burkhard; Heiselman, Darell; Leishman, Amy G; Zhu, Yajun E; Reinhart, Konrad; RESPOND investigators,
Informations sur la publication:Critical care, 14, 6, page (R229)
Statut de publication:Publié, 2010
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Aged
Biological Markers -- blood
Double-Blind Method
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Protein C -- administration & dosage -- metabolism
Recombinant Proteins -- administration & dosage
Sepsis -- blood -- drug therapy
Treatment Outcome
Note générale:Clinical Trial, Phase II
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1364-8535
info:doi/10.1186/cc9382
info:pii/cc9382
info:scp/78650298220
info:pmid/21176144
PMC3219981